(Reuters) - Excluding special items, J&J said it earned $1.16 per share in the first quarter. Analysts on average expected $1.04 per share, according to Reuters Estimates.
"Pharmaceuticals led the way," said Bank of America analyst Glenn Novarro, citing sizzling demand for epilepsy drug Topamax and the company's schizophrenia medicines.
Read more at Reuters.com Hot Stocks News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment